Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06949423 · ClinicalTrials.gov registry record · NA

Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder

A NA study, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target

NCT06949423: Recruiting NA study, sponsored by Stanford University.

NCT06949423 is a NA study that is actively recruiting participants, run by Stanford University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06949423, a NA study, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.

Interventions

  • DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active
  • DEVICE Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-12-17
Est. Completion 2030-06-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06949423

The ClinicalTrials.gov registry entry for NCT06949423 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active is the first listed.

NCT06949423 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06949423 about?

NCT06949423 is a clinical study titled "Assessing the Impact of dTMS on Neural Targets Associated With Alcohol Use Disorder". The purpose of this study is to evaluate the efficacy of deep transcranial magnetic stimulation as a treatment for Veterans with Alcohol Use Disorder (AUD) to decrease the exceedingly high rate of relapse associated with this condition.

What is the current status of trial NCT06949423?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-17. Estimated completion is 2030-06-30.

What interventions are being tested in trial NCT06949423?

The interventions under investigation include: Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Active (DEVICE), Deep Transcranial Magnetic Stimulation (dTMS) H7 coil - Sham (DEVICE).

Who is sponsoring clinical trial NCT06949423?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.